Authors

What Donald Trump's election means for pharma: Insight from the 2024 Global Pharma and Biotech Summit

A panel at the Financial Times’ 2024 Global Pharma and Biotech Summit in London analyzed what the re-election of Trump could mean to the pharmaceutical industry.

It’s more than just the money: The importance of analyzing both economic and noneconomic key issues for a successful health care transaction

An economic comeback, conservative pricing, private equity: What does this mean for potential sellers of health care businesses?

Vaccines in the post-COVID-19 world: Distrust amid promising developments

At the Financial Times Global Pharma and Biotech Summit 2024, a panel discussed the potential of mRNA technology in developing cancer vaccines amid distrust from the public.

Occupied Turnkey Properties with 5.75% Fixed Rates and In-House PM!

The Payment Toolbox: How Third-Party Financing Can Improve the Patient Journey While Supporting Your Practice

Incident-to billing in mental health: What physicians and other clinicians need to know about compliance and reimbursement

Navigate complex Medicare rules and payer requirements to protect your practice from audits and maximize reimbursement

William Schaffner, M.D.: Our vaccination problem is an education problem

An expert physician panel discusses how vaccine policy has gone wrong under the Trump administration, why misinformation has flourished and what individual physicians can do to win back patient trust.

Medicine under attack: How physicians can help their patients navigate the disinformation age

Physicians have credibility but may need new forms of communication to reach patients and counter inaccuracies.

Subscribe to the free Medical Device & Technology newsletter

Finding financial partners: Why physicians need a support team to sustain personal and organizational finances

Physicians help patients improve their physical health. Here’s how they can work with others to improve their own fiscal health.

Point-of-care testing, with Daniel Krajcik, D.O., MBA

Daniel Krajcik, D.O., MBA, a primary care physician with the Cleveland Clinic, joins the show to break down the real-world considerations of bringing rapid testing into the office.

Post-Acute Care Coordination: 12 Key Findings and Recommended Actions

Revolutionizing Healthcare Staffing: How CARES is Addressing the Nursing Shortage

Drowning in Documentation? Discover How AI Can Cut Hours and Capture More Revenue